PCVX
Price:
$90.43
Market Cap:
$11.27B
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc....[Read more]
Industry
Biotechnology
IPO Date
2020-06-12
Stock Exchange
NASDAQ
Ticker
PCVX
According to Vaxcyte, Inc.’s latest financial reports and current stock price. The company's current ROE is -23.53%. This represents a change of 226.16% compared to the average of -7.22% of the last 4 quarters.
The mean historical ROE of Vaxcyte, Inc. over the last ten years is -10.36%. The current -23.53% ROE has changed 127.11% with respect to the historical average. Over the past ten years (40 quarters), PCVX's ROE was at its highest in in the December 2019 quarter at 13.75%. The ROE was at its lowest in in the March 2019 quarter at -22.58%.
Average
-10.36%
Median
-25.39%
Minimum
-55.72%
Maximum
51.08%
Discovering the peaks and valleys of Vaxcyte, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 38.77%
Maximum Annual ROE = 51.08%
Minimum Annual Increase = -191.67%
Minimum Annual ROE = -55.72%
Year | ROE | Change |
---|---|---|
2023 | -32.43% | 29.04% |
2022 | -25.13% | -28.69% |
2021 | -35.24% | 38.77% |
2020 | -25.39% | -150.49% |
2019 | 50.29% | -1.53% |
2018 | 51.08% | -191.67% |
The current ROE of Vaxcyte, Inc. (PCVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.93%
5-year avg
-13.58%
10-year avg
-10.36%
Vaxcyte, Inc.’s ROE is greater than Larimar Therapeutics, Inc. (-35.87%), greater than Syndax Pharmaceuticals, Inc. (-64.34%), greater than Merus N.V. (-45.38%), greater than Sutro Biopharma, Inc. (-97.01%), greater than Arcellx, Inc. (-8.28%), greater than Ventyx Biosciences, Inc. (-54.94%), greater than Immunocore Holdings plc (-14.67%), less than DICE Therapeutics, Inc. (56.07%), greater than Nuvalent, Inc. (-28.63%), greater than Viridian Therapeutics, Inc. (-45.47%), greater than Legend Biotech Corporation (-29.69%), greater than Apellis Pharmaceuticals, Inc. (-103.92%), greater than Travere Therapeutics, Inc. (-541.59%), greater than Akero Therapeutics, Inc. (-32.52%), less than BioMarin Pharmaceutical Inc. (6.22%), greater than Liquidia Corporation (-155.77%), less than Bio-Techne Corporation (7.36%),
Company | ROE | Market cap |
---|---|---|
-35.87% | $419.21M | |
-64.34% | $1.28B | |
-45.38% | $2.94B | |
-97.01% | $193.78M | |
-8.28% | $4.45B | |
-54.94% | $196.58M | |
-14.67% | $1.59B | |
56.07% | $2.27B | |
-28.63% | $6.61B | |
-45.47% | $1.53B | |
-29.69% | $6.95B | |
-103.92% | $4.31B | |
-541.59% | $1.63B | |
-32.52% | $2.14B | |
6.22% | $12.66B | |
-155.77% | $909.84M | |
7.36% | $12.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxcyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxcyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Vaxcyte, Inc.'s ROE?
How is the ROE calculated for Vaxcyte, Inc. (PCVX)?
What is the highest ROE for Vaxcyte, Inc. (PCVX)?
What is the 3-year average ROE for Vaxcyte, Inc. (PCVX)?
What is the 5-year average ROE for Vaxcyte, Inc. (PCVX)?
How does the current ROE for Vaxcyte, Inc. (PCVX) compare to its historical average?